Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Group name EquipePC
Item Type Note
Note The following values have no corresponding Zotero field:
auth-address: Department of Molecular Biology, Strasbourg University Hospital, EA 3430, Strasbourg University, Strasbourg, France; the Francophone Intergroup of Thoracic Oncology, Paris, France. Electronic address: michele.faller@chru-strasbourg.fr. Department of Molecular Biology, Georges Pompidou European Hospital, AP-HP, Paris, Universite Paris Descartes, Paris, France. Department of Biostatistics and Epidemiology, Institut Gustave-Roussy, Villejuif, France. Department of Genetics, Laboratory of Medical Genetics, CHU de Caen, Caen, France. Oncology and Molecular Genetics Laboratory, Division of Biochemistry and Molecular Biology, Center for Disease Biology, CHRU de Lille, Lille Cedex, France. Molecular Biology Laboratory, CHU de Montpellier, Montpellier, France. Biochemistry Laboratory, CHU de Nantes, Nantes, France. Molecular Biology Laboratory, CHU de Clermont-Ferrand, Clermont-Ferrand, France. Laboratory of Oncology and Biological Transfer, CHU de Marseille, Marseille, France. Medical Genetics and Functional Genomics, INSERM UMR S910, Marseille, France. Molecular Biology Unit, Centre GF Leclerc, Dijon, France. Molecular Biology Laboratory, CHU de Dijon, Dijon, France. Univ Franche-Comte, EA 3181, FED4234, and CHU Besancon, Besancon, France. UM Biochemistry and Cancer Biotherapy, Division of Biology, CHU Grenoble, Grenoble Cedex 09, France. Oncogenetics Laboratory, Plateforme HUVEGEN, Institut Curie-Hopital Rene Huguenin, Saint-Cloud, France. Pharmacology Unit, Department of Tumor Biology, Institut Curie, Paris, France. Unit of Lung Molecular Pathology of the Hospital Platform of Cancer Molecular Genetics Midi-Pyrenees, Pathological Anatomy Service, CHU Toulouse Rangueil, Toulouse, France. Department of Anatomy and Pathological Cytology, Hospices Civils de Lyon, Hopital Edouard Herriot, Lyon, France. Laboratory of Somatic Cancer Genetics, CHU de Rennes, Rennes, France. Molecular Biology Laboratory, Hopital de Hautepierre, Strasbourg, France. Translational Research Laboratory, Institut Gustave Roussy, Villejuif Cedex, France. the Francophone Intergroup of Thoracic Oncology, Paris, France. the Francophone Intergroup of Thoracic Oncology, Paris, France; Department of Molecular Biology, Georges Pompidou European Hospital, AP-HP, Paris, Universite Paris Descartes, Paris, France. the Francophone Intergroup of Thoracic Oncology, Paris, France; UMR 1086 INSERM and the Department of Pneumlogy and Thoracic Oncology, Caen University Hospital, Caen, France. the Francophone Intergroup of Thoracic Oncology, Paris, France; Pneumology Service, Assistance Publique Hopitaux de Paris, Hopital Tenon, GRC-04 Theranoscan, Universite Paris VI, Paris Cedex 20, France.
alt-title: The Journal of molecular diagnostics : JMD
number: 1
accession-num: 24183959
Tags _EndnoteXML import
Date Added 2018/11/14 - 12:07:50
Date Modified 2018/11/14 - 12:07:50
Parent item A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting--IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés